Patent details

Basic Information

Publication number:

EP1938821

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP081529232

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Dosage forms of an epothilone analogue for the treatment of cancer

French Title of Invention:

Formulation d'un analogue de l'epothilone destinée au traitement du cancer

German Title of Invention:

Formulierung eines Epothilon-Analogs zur Krebsbehandlung

SPC Number:

Dates

Filing date:

22/01/2002

Grant date:

30/03/2016

EP Publication Date:

30/03/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/07/2008

EP B1 Publication Date:

30/03/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/01/2017

Expiration date:

22/01/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/01/2002

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Inventor

1

Name:

Raghavan Krishnaswamy Srinivas

Address:

United States (US)

2

Name:

Panaggio Andrea

Address:

United States (US)

3

Name:

Varia Sailesh Amilal

Address:

United States (US)

4

Name:

Malloy Timothy M.

Address:

United States (US)

5

Name:

Bandyopadhyay Rebanta

Address:

United States (US)

Priority

1

Priority Number:

264228 P

Priority Date:

25/01/2001

Priority Country:

United States (US)

2

Priority Number:

290008 P

Priority Date:

11/05/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/425;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages